400-859-2883
Your location:Home >News center >Industry News

Industry News

01-302023

Current Therapies For Non-Small Cell Lung…

Here, we will introduce the current targeted drug therapies and immunotherapies therapies for NSCLC based on official information from the American Cancer Society.

Current Therapies For Non-Small Cell Lung Cancer (NSCLC)
01-292023

Bystander Effect of Antibody-drug Conjuga…

Summarizing the current preclinical and clinical evidence about bystander effect of ADCs in solid tumors.

Bystander Effect of Antibody-drug Conjugates (ADCs)
01-132023

2022 FDA Approval & Potencial Blockbu…

FDA approved 37 novel drugs IN 2022, lets find the potencial blockbusters.

2022 FDA Approval & Potencial Blockbusters
01-092023

Summary of 10 Approved COVID-19 Small Mol…

So far, the need for effective therapies for COVID-19 remains high. As peoples understanding of the structure, function and pathogenic processes of the novel coronavirus has improved, many sm…

Summary of 10 Approved COVID-19 Small Molecule Drugs
12-292022

Semaglutide: A Star Product In The Field …

In this article, we will introduce this new star semaglutide in the hypoglycemic and weight loss field.

Semaglutide: A Star Product In The Field of Hypoglycemic And Weight Loss
12-272022

Clinical Toxicity Of Antibody Drug Conjug…

Antibody-drug conjugates side effects should not be ignored.

Clinical Toxicity Of Antibody Drug Conjugates